// App-Quantinova.ai

: Long-term Tolvaptan therapy in the treatment of SIAD in Elderly- A case report with challenging cytochrome P 450 drug interactions

Researchers

Presenter

  • Keerthi Madhurya Kethireddi

Principal Investigators

  • Sathish Babu Parthasarathy

Medical Centers

  • Princess Royal Hospital, Endocrinology & Diabetes, Haywards Heath, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Addison's disease

Biomarkers

  • Adrenocorticotropic hormone

  • Cortisol

  • Cytochrome P450 Family 3 Subfamily A Member 4

Drug/Treatment

  • Demeclocycline

  • Hydrocortisone

  • Itraconazole

  • Canadiol

  • Fluticasone

  • Azelastine/fluticasone propionate

  • vasopressin Injection

  • SAMSCA

  • Tetracosactide

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved